Rik V.
- Country
- Belgium
- Department
- Neurology
Research Overview
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia
- A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study with a Long-Term Extension Treatment Period to Assess the Efficacy and Safety of JNJ-63733657, an Anti-tau Monoclonal Antibody, in Participants with Early Alzheimer's Disease
- Efficacy and Safety Evaluation of Latozinemab in Patients with Frontotemporal Dementia Due to Progranulin Gene Mutations: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 99 of 203 partner sites.
Specializations
Alzheimer's Disease Research
This investigator specializes in studying various stages of Alzheimer's disease, with particular emphasis on early intervention and cognitive decline prevention. Their research encompasses mild cognitive impairment (MCI) and prodromal Alzheimer's stages.
- Early-stage Alzheimer's interventions
- Cognitive function assessment
- Preclinical Alzheimer's studies
Their work includes evaluation of novel therapeutic approaches targeting tau proteins and cognitive preservation strategies.
Frontotemporal Dementia Studies
The investigator conducts specialized research in Frontotemporal Dementia (FTD), with specific focus on cases involving progranulin mutations. Their expertise extends to innovative therapeutic approaches for FTD treatment.
- FTD-GRN mutation research
- Novel therapeutic development
- Disease progression monitoring
Their research includes assessment of targeted treatments and innovative delivery methods for FTD therapies.
Cognitive Assessment and Monitoring
The investigator focuses on comprehensive cognitive assessment methodologies, utilizing advanced metrics such as the Clinical Dementia Rating Scale and specialized cognitive testing protocols.
- Cognitive decline measurement
- Clinical assessment tools
- Long-term cognitive monitoring
Their work involves tracking cognitive changes and evaluating treatment effectiveness in neurodegenerative conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.